Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

THE PRIORITIZE STUDY: A Pragmatic, Randomized Study of Oral Regimens for Hepatitis C: Transforming Decision-Making for Patients, Providers, and Stakeholders

NCT02786537 is registered in ClinicalTrials.gov with University of Florida as lead sponsor.

NCT NCT02786537
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT02786537 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
THE PRIORITIZE STUDY: A Pragmatic, Randomized Study of Oral Regimens for Hepatitis C: Transforming Decision-Making for Patients, Providers, and Stakeholders
Lead sponsor
University of Florida
Phase
Phase 4
Overall status
Completed
Start date
June 30, 2016
Completion date
September 2, 2020
Enrollment
1,275 (actual)
Sites
38

Conditions

As the registry lists them; a condition with its own page is linked.

chronic hepatitis c